157 related articles for article (PubMed ID: 27713424)
1. 5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Saldanha G; Joshi K; Lawes K; Bamford M; Moosa F; Teo KW; Pringle JH
Mod Pathol; 2017 Jan; 30(1):60-68. PubMed ID: 27713424
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
[TBL] [Abstract][Full Text] [Related]
3. Breslow density is a novel prognostic feature in cutaneous malignant melanoma.
Rashed H; Flatman K; Bamford M; Teo KW; Saldanha G
Histopathology; 2017 Jan; 70(2):264-272. PubMed ID: 27502743
[TBL] [Abstract][Full Text] [Related]
4. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
Shen Y; Wang L; Ou J; Wang B; Cen X
Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
[No Abstract] [Full Text] [Related]
5. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
6. Breslow Density Is a Novel Prognostic Feature That Adds Value to Melanoma Staging.
Saldanha G; Yarrow J; Pancholi J; Flatman K; Teo KW; Elsheik S; Harrison R; O'Riordan M; Bamford M
Am J Surg Pathol; 2018 Jun; 42(6):715-725. PubMed ID: 29462090
[TBL] [Abstract][Full Text] [Related]
7. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Lee JJ; Cook M; Mihm MC; Xu S; Zhan Q; Wang TJ; Murphy GF; Lian CG
Oncotarget; 2015 Nov; 6(35):37995-8004. PubMed ID: 26462027
[TBL] [Abstract][Full Text] [Related]
8. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
9. A Novel Numerical Scoring System for Melanoma Tumor-infiltrating Lymphocytes Has Better Prognostic Value Than Standard Scoring.
Saldanha G; Flatman K; Teo KW; Bamford M
Am J Surg Pathol; 2017 Jul; 41(7):906-914. PubMed ID: 28368925
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
[TBL] [Abstract][Full Text] [Related]
11. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
[TBL] [Abstract][Full Text] [Related]
12. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
Ipenburg NA; Lo SN; Vilain RE; Holtkamp LHJ; Wilmott JS; Nieweg OE; Thompson JF; Scolyer RA
J Am Acad Dermatol; 2020 Apr; 82(4):910-919. PubMed ID: 31682859
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Pavlova O; Fraitag S; Hohl D
J Invest Dermatol; 2016 Dec; 136(12):2453-2461. PubMed ID: 27456754
[TBL] [Abstract][Full Text] [Related]
15. EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A; Battistella M; Feugeas JP; Pages C; Basset-Seguin N; Mazouz Dorval S; Funck Brentano E; Sadoux A; Podgorniak MP; Menashi S; Janin A; Lebbé C; Mourah S
Exp Dermatol; 2016 Aug; 25(8):618-22. PubMed ID: 27060463
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Lee JJ; Vilain RE; Granter SR; Hu NR; Bresler SC; Xu S; Frank AH; Mihm MC; Saw RP; Fletcher CD; Scolyer RA; Murphy GF; Lian CG
J Cutan Pathol; 2017 Mar; 44(3):249-255. PubMed ID: 28032662
[TBL] [Abstract][Full Text] [Related]
17. Global and mitosis-specific interobserver variation in mitotic count scoring and implications for malignant melanoma staging.
Saldanha G; Ali R; Bakshi A; Basiouni A; Bishop R; Colloby P; Craig P; Da Forno P; Edward S; Espinosa de Los Monteros O; Evans A; Jamieson L; Rytina E; Bamford M
Histopathology; 2020 May; 76(6):803-813. PubMed ID: 31879972
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis.
Nagore E; Oliver V; Botella-Estrada R; Moreno-Picot S; Insa A; Fortea JM
Melanoma Res; 2005 Jun; 15(3):169-77. PubMed ID: 15917698
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
